Evidence map›Paper›PMID 37779614›Full record

ArticleFrontiers in psychiatry2023

Patient reported preferences for sleep interventions among women receiving buprenorphine for opioid use disorder.

Michelle Eglovitch, Anna Beth Parlier-Ahmad, Catherine Legge, Sajanee Chithranjan, Saisriya Kolli, Stephanie Violante, Joseph M Dzierzewski, Andrew Stephen Huhn, Allison Wilkerson, Caitlin Eileen Martin

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Michelle EglovitchDepartment of Psychology, Virginia Commonwealth University, Richmond, VA, United States.
Anna Beth Parlier-AhmadDepartment of Psychology, Virginia Commonwealth University, Richmond, VA, United States.
Catherine LeggeSchool of Medicine, Virginia Commonwealth University, Richmond, VA, United States.
Sajanee ChithranjanSchool of Medicine, Virginia Commonwealth University, Richmond, VA, United States.
Saisriya KolliSchool of Medicine, Virginia Commonwealth University, Richmond, VA, United States.
Stephanie ViolanteDepartment of Psychology, Virginia Commonwealth University, Richmond, VA, United States.
Joseph M DzierzewskiNational Sleep Foundation, Washington, DC, United States.
Andrew Stephen HuhnSchool of Medicine, Johns Hopkins University, Baltimore, MD, United States.
Allison WilkersonDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States.
Caitlin Eileen MartinInstitute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, United States.
Virginia Commonwealth University · USJohns Hopkins Medicine · USMedical University of South Carolina · USNational Sleep Foundation · US

Funding

Research Supplement to Promote Diversity in Health Related ResearchUL1TR002649 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI MOELLER, FREDERICK GERARD · 2018 to 2022
$19.1M
TRAINING IN THE PHARMACOLOGY OF ABUSED DRUGST32DA007027 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI William L. Dewey · 1985 to 2026
$14.7M
Adaptation and Refinement of a Clinically Applicable Phenotypic Battery to Individualize Opioid Use Disorder Treatment for Women Through the Postpartum PeriodK23DA053507 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI MARTIN, CAITLIN EILEEN · 2021 to 2025
$1.0M
NCATS NIH HHS UL1 TR002649NIDA NIH HHS K23 DA053507NIDA NIH HHS T32 DA007027
6 · The paper itself

Abstract

Aim: Among individuals receiving medication for OUD (MOUD), insomnia is highly prevalent and increases the risk for negative OUD outcomes. However, little is known about MOUD patient-reported preferences for insomnia treatments among women with OUD. This mixed-methods study explored acceptability of and patient preferences for sleep interventions among women in OUD treatment. Methods: This is an analysis from an ongoing cross-sectional survey and interview study investigating the relationship between sleep and OUD recovery. The parent study is actively enrolling non-pregnant women between 18-45 years stabilized on buprenorphine from an outpatient program. Participants complete measures including the Insomnia Severity Index (ISI), with scores of ≥10 identifying clinically significant insomnia symptoms. A sub-sample who met this threshold completed semi-structured interviews. Descriptive statistics were generated for survey responses, and applied thematic analysis was used for interview data. Results: Participants selected for the qualitative interview ( Conclusions: Many women receiving MOUD have concomitant insomnia symptoms, and desire availability of both pharmacologic and behavioral sleep interventions within the OUD treatment setting. Qualitative findings underscore the need for evidence-based sleep interventions that account for the unique socioenvironmental factors that may impact strategy implementation in this population.

Indexed as

buprenorphineinsomniaopioid use disordersleepsubstance use disorder treatment

Identifiers

PMID37779614
PMCPMC10537926
OpenAlexW4386741874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.